Found 178 results
Filters: Keyword is Male  [Clear All Filters]
Roh D, Sun C-H, Murthy S, Elkind MSV, Bruce SS, Melmed K, Ironside N, Boehme A, Doyle K, Woo D et al..  2019.  Hematoma Expansion Differences in Lobar and Deep Primary Intracerebral Hemorrhage.. Neurocrit Care. 31(1):40-45.
Denman AJ, Sammons JD, Victor JD, Di Lorenzo PM.  2019.  Heterogeneity of neuronal responses in the nucleus of the solitary tract suggests sensorimotor integration in the neural code for taste.. J Neurophysiol. 121(2):634-645.
Demertzi A, Tagliazucchi E, Dehaene S, Deco G, Barttfeld P, Raimondo F, Martial C, Fernández-Espejo D, Rohaut B, Voss HU et al..  2019.  Human consciousness is supported by dynamic complex patterns of brain signal coordination.. Sci Adv. 5(2):eaat7603.
Doria JW, Forgacs PB.  2019.  Incidence, Implications, and Management of Seizures Following Ischemic and Hemorrhagic Stroke.. Curr Neurol Neurosci Rep. 19(7):37.
Seligman L, Kovanlikaya I, Pisapia DJ, Naeger DM, Magge R, Fine HA, Chiang GC.  2019.  Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling.. AJR Am J Roentgenol. 212(4):883-891.
Leasure AC, Qureshi AI, Murthy SB, Kamel H, Goldstein JN, Walsh KB, Woo D, Shi F-D, Huttner HB, Ziai WC et al..  2019.  Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage.. Stroke. 50(8):2016-2022.
Andersen BM, Miranda C, Hatzoglou V, DeAngelis LM, Miller AM.  2019.  Leptomeningeal metastases in glioma: The Memorial Sloan Kettering Cancer Center experience.. Neurology. 92(21):e2483-e2491.
Daileda T, Vahidy FS, Chen PRoc, Kamel H, Liang CW, Savitz SI, Sheth SA.  2019.  Long-term retreatment rates of cerebral aneurysms in a population-level cohort.. J Neurointerv Surg. 11(4):367-372.
Roh DJ, Albers DJ, Magid-Bernstein J, Doyle K, Hod E, Eisenberger A, Murthy S, Witsch J, Park S, Agarwal S et al..  2019.  Low hemoglobin and hematoma expansion after intracerebral hemorrhage.. Neurology. 93(4):e372-e380.
Weaver J, Sarva H, Barone D, Bobker S, Bushara K, Hiller A, Ishii M, Jankovic J, Lakhani S, Niotis K et al..  2019.  McLeod syndrome: Five new pedigrees with novel mutations.. Parkinsonism Relat Disord. 64:293-299.
Zhang S, Chiang GChia-Yi, Magge RS, Fine HAlan, Ramakrishna R, Chang EWang, Pulisetty T, Wang Y, Zhu W, Kovanlikaya I.  2019.  MRI based texture analysis to classify low grade gliomas into astrocytoma and 1p/19q codeleted oligodendroglioma.. Magn Reson Imaging. 57:254-258.
Ivanidze J, Lum M, Pisapia D, Magge R, Ramakrishna R, Kovanlikaya I, Fine HA, Chiang GC.  2019.  MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma.. J Neuroimaging. 29(3):357-363.
Omran SSalehi, Chatterjee A, Chen ML, Lerario MP, Merkler AE, Kamel H.  2019.  National Trends in Hospitalizations for Stroke Associated With Infective Endocarditis and Opioid Use Between 1993 and 2015.. Stroke. 50(3):577-582.
Perumal J, Fox RJ, Balabanov R, Balcer LJ, Galetta S, Makh S, Santra S, Hotermans C, Lee L.  2019.  Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE.. BMC Neurol. 19(1):116.
Lin M-H, Kamel H, Singer DE, Wu Y-L, Lee M, Ovbiagele B.  2019.  Perioperative/Postoperative Atrial Fibrillation and Risk of Subsequent Stroke and/or Mortality.. Stroke. 50(6):1364-1371.
Cabrera LY, Sarva H, Sidiropoulos C.  2019.  Perspectives on the Earlier Use of Deep Brain Stimulation for Parkinson Disease from a Qualitative Study of U.S. Clinicians.. World Neurosurg. 128:e16-e20.
Mandava P, Murthy SB, Shah N, Samson Y, Kimmel M, Kent TA.  2019.  Pooled analysis suggests benefit of catheter-based hematoma removal for intracerebral hemorrhage.. Neurology. 92(15):e1688-e1697.
Fridman EA, Osborne JR, Mozley PD, Victor JD, Schiff ND.  2019.  Presynaptic dopamine deficit in minimally conscious state patients following traumatic brain injury.. Brain. 142(7):1887-1893.
Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Rúa SMHurtado, Park C, Gillen KM, Nguyen TD et al..  2019.  Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.. Brain. 142(1):133-145.
Zhang S, Nguyen TD, Rúa SMHurtado, Kaunzner UW, Pandya S, Kovanlikaya I, Spincemaille P, Wang Y, Gauthier SA.  2019.  Quantitative Susceptibility Mapping of Time-Dependent Susceptibility Changes in Multiple Sclerosis Lesions.. AJNR Am J Neuroradiol. 40(6):987-993.
Saber H, Navi BB, Grotta JC, Kamel H, Bambhroliya A, Vahidy FS, Chen PRoc, Blackburn S, Savitz SI, McCullough L et al..  2019.  Real-World Treatment Trends in Endovascular Stroke Therapy.. Stroke. 50(3):683-689.
Schilling LPorcello, Pascoal TA, Zimmer ER, Mathotaarachchi S, Shin M, Rieder CRoberto de, Gauthier S, Palmini A, Rosa-Neto P.  2019.  Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.. Mol Neurobiol. 56(7):4916-4924.
Kamel H, Okin PM, Merkler AE, Navi BB, Campion TR, Devereux RB, Diaz I, Weinsaft JW, Kim J.  2019.  Relationship between left atrial volume and ischemic stroke subtype.. Ann Clin Transl Neurol. 6(8):1480-1486.
Mielke O, Bril V, Cornblath DR, Lawo J-P, van Geloven N, Hartung H-P, Lewis RA, Merkies ISJ, Sobue G, Durn B et al..  2019.  Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study.. J Peripher Nerv Syst. 24(1):72-79.
Ishii M, Kamel H, Iadecola C.  2019.  Retinol Binding Protein 4 Levels Are Not Altered in Preclinical Alzheimer's Disease and Not Associated with Cognitive Decline or Incident Dementia.. J Alzheimers Dis. 67(1):257-263.